Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|11|843-848

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.11, 2015-11, pp. : 843-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Y. S. Sakin et al.

By  

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 1037-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 3, 2015-03 ,pp. : 254-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

P137: Assessment of outcomes of triple combination therapy including telaprevir in treating chronic hepatitis C in hemodialysis patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 88-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 12, 2015-12 ,pp. : 992-1001

John Wiley & Sons Inc

Access to resources Recommend Favorite

Telaprevir‐based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 9, 2013-11 ,pp. : 1076-1085

John Wiley & Sons Inc

Access to resources Recommend Favorite